Review Articles

2020

Phenotypical and potential functional characteristics of different immune cells expressing CD28H/B7‐H5 and their relationship with cancer prognosis
C. Zhong, Q. Lang, J. Yu, S. Wu, F. Xu, Y. Tian
Volume 200, Issue 1, Pages 12-21

FoxP3 in Treg cell biology: a molecular and structural perspective
G. Deng, X. Song, M. I. Greene
Volume 199, Issue 3, Pages 255-262

Immunological tolerance of low‐risk HPV in recurrent respiratory papillomatosis
R. Ivancic, H. Iqbal, B. deSilva, Q. Pan and L. Matrka
Volume 199, Issue 2, Pages 119-130

How to dissect the plasticity of antigen‐specific immune response: a tissue perspective
D. Amodio, V. Santilli, et al
Volume 199, Issue 2, Pages 131-142

Immunological tolerance of low‐risk HPV in recurrent respiratory papillomatosis
R. Ivancic, H. Iqbal, B. deSilva, Q. Pan and L. Matrka
Volume 199, Issue 2, Pages 119-130

Microbial interactions in the atopic march
B. Nibbering and N. D. J. Ubags
Volume 199, Issue 1, Pages 12-23

Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease
M. N. Quraishi, W. Shaheen, Y. H. Oo and T. H. Iqbal
Volume 199, Issue 1, Pages 24-38

2019

Birth and coming of age of islet autoantibodies
E. Bonifacio and P. Achenbach
Volume 198, Issue 3, Pages 294-305

Islet-Immune Interactions in Type 1 Diabetes: The Nexus of Beta Cell Destruction
L Peters, A. Posgai, T. Brusko
Volume 198, Issue 3, Pages 326-340

Immune cell trafficking to the islets during type 1 diabetes
A.M. Sandor, J. Jacobelli, R.S. Friedman
Volume 198, Issue 3, Pages 314-325

HIPs and HIP-reactive T cells
T.A. Wiles and T. Delong
Volume 198, Issue 3, Pages 306-313

A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens
A. Abraham, G. Ostroff, S. M. Levitz and P. C. F. Oyston
Volume 198, Issue 2, Pages 143-152

Formulation technologies for oral vaccines
R. R. C. New
Volume 198, Issue 2, Pages 153-169

Vaccines for emerging pathogens: prospects for licensure
E. D. Williamson and G. E. Westlake
Volume 198, Issue 2, Pages 170-183

Influence of maternal microbiota during pregnancy on infant immunity
D. D. Nyangahu and H. B. Jaspan
Volume 198, Issue 1, Pages 47-56

Overview of procalcitonin in pregnancy and in pre‐eclampsia
A. Mangogna, C. Agostinis, G. Ricci, F. Romano and R. Bulla
Volume 198, Issue 1, Pages 37-46

The role of neutrophil activation in determining the outcome of pregnancy and modulation by hormones and/or cytokines
S. Hahn, P. Hasler, L. Vokalova, S. V. van Breda, O. Lapaire, N. G. Than, I. Hoesli and S. W. Rossi
Volume 198, Issue 1, Pages 24-36

Embryonic extracellular vesicles as informers to the immune cells at the maternal–fetal interface
E. Giacomini, E. Alleva, G. Fornelli, A. Quartucci, L. Privitera, V. S. Vanni and P. Viganò
Volume 198, Issue 1, Pages 15-23

From early adversities to immune activation in psychiatric disorders: the role of the sympathetic nervous system
V. Mondelli and A. C. Vernon
Volume 197, Issue 3, Pages 319-328

Depressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?
C. D. Moulton, P. Pavlidis, C. Norton, S. Norton, C. Pariante, B. Hayee and N. Powell
Volume 197, Issue 3, Pages 308-318

The immune system and psychiatric disease: a basic science perspective
F. C. Bennett and A. V. Molofsky
Volume 197, Issue 3, Pages 294-307

Neuroimmunology – the past, present and future
E. Nutma, H. Willison, G. Martino and S. Amor
Volume 197, Issue 3, Pages 278-293

T cell metabolism in chronic viral infection
L. J. Pallett, N. Schmidt and A. Schurich
Volume 197, Issue 2, Pages 143-152

Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
Y.‐R. Yu and P.‐C. Ho
Volume 197, Issue 2, Pages 153-160

Sensing between reactions – how the metabolic microenvironment shapes immunity
J. Lötscher and M. L. Balmer
Volume 197, Issue 2, Pages 160-169

Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis
U. Fearon, M. M. Hanlon, S. M. Wade and J. M. Fletcher
Volume 197, Issue 2, Pages 170-180

Immune cell metabolism in autoimmunity
X. Teng, W. Li, C. Cornaby and L. Morel
Volume 197, Issue 2, Pages 181-192

Metabolism at the centre of the host–microbe relationship
K. M. Maslowski
Volume 197, Issue 2, Pages 193-204

From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics
D. Bending and M. Ono
Volume 197, Issue 1, Pages 14-23

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases
A. Mohr, M. Atif, R. Balderas, G. Gorochov and M. Miyara
Volume 197, Issue 1, Pages 24-35

Mechanisms of human FoxP3+ Treg cell development and function in health and disease
M. Attias, T. Al‐Aubodah and C. A. Piccirillo
Volume 197, Issue 1, Pages 36-51

Methods to manufacture regulatory T cells for cell therapy
K. N. MacDonald, J. M. Piret and M. K. Levings
Volume 197, Issue 1, Pages 52-63

Delayed disease progression in HIV‐2: the importance of TRIM5α and the retroviral capsid
M. T. Boswell and S. L. Rowland‐Jones
Volume 196, Issue 3, Pages 305-317

Extracellular vesicles, news about their role in immune cells: physiology, pathology and diseases
J. Meldolesi
Volume 196, Issue 3, Pages 318-327

Emerging viruses and current strategies for vaccine intervention
B. Afrough, S. Dowall and R. Hewson
Volume 169, Issue 2, Pages 157-166

HLA‐E: exploiting pathogen‐host interactions for vaccine development
H. R. Sharpe, G. Bowyer, S. Brackenridge and T. Lambe
Volume 169, Issue 2, Pages 167-177

Novel multi‐component vaccine approaches for Burkholderia pseudomallei
L. Morici, A. G. Torres and R. W. Titball
Volume 169, Issue 2, Pages 178-188

Novel approaches for the design, delivery and administration of vaccine technologies
J. Wallis, D. P. Shenton and R. C. Carlisle
Volume 169, Issue 2, Pages 189-204

Mucosal vaccines and technology
A. Miquel‐Clopés, E. G. Bentley, J. P. Stewart and S. R. Carding
Volume 169, Issue 2, Pages 205-214

Dendritic cells, T cells and their interaction in rheumatoid arthritis
P. Wehr, H. Purvis, S.‐C. Law and R. Thomas
Volume 196, Issue 1, April 2019, Page 12-27

Exploring immunomodulation by endocrine changes in Lady Windermere syndrome
M. R. Holt, J. J. Miles, W. J. Inder and R. M. Thomson
Volume 196, Issue 1, April 2019, Pages 28-38

The immunopathogenesis of fibrosis in systemic sclerosis
M. Brown and S. O’Reilly
Volume 195, Issue 3, March 2019, Pages 310-321

Behçet’s syndrome as a tool to dissect the mechanisms of thrombo‐inflammation: clinical and pathogenetic aspects
M. Becatti, G. Emmi, A. Bettiol, E. Silvestri, G. Di Scala, N. Taddei, D. Prisco and C. Fiorillo
Volume 195, Issue 3, March 2019, Pages 322-333

Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment
A. Pawłowska, D. Suszczyk, K. Okła, B. Barczyński, J. Kotarski and I. Wertel
Volume 195, Issue 3, March 2019, Pages 334-344

Inflammation in osteoarthritis: is it time to dampen the alarm(in) in this debilitating disease?
M. H. J. van den Bosch
Volume 195, Issue 2, February 2019, Pages 153-166

Enterovirus infection and type 1 diabetes: unraveling the crime scene
T. Rodriguez‐Calvo
Volume 195, Issue 1, January 2019, Pages 15-24

Pathogen infections and primary biliary cholangitis
A. Tanaka, P. S. C. Leung and M. E. Gershwin
Volume 195, Issue 1, January 2019, Pages 25-34

Pathogens and autoimmune hepatitis
U. Christen, E. Hintermann
Volume 195, Issue 1, January 2019, Pages 35-51

The potential role for infections in the pathogenesis of autoimmune Addison’s disease
A. Hellesen, E. Bratland
Volume 195, Issue 1, January 2019, Pages 52-63

Mechanisms of lymphatic system‐specific viral replication and its potential role in autoimmune disease
S.‐K. Friedrich, P. A. Lang, J. Friebus‐Kardash, V. Duhan, J. Bezgovsek and K. S. Lang
Volume 195, Issue 1, January 2019, Pages 64-73

The microbiome in autoimmune diseases
F. De Luca and Y. Shoenfeld
Volume 195, Issue 1, January 2019, Pages 74-85

2018

Immune‐bone interplay in the structural damage in rheumatoid arthritis
N. Komatsu and H. Takayanagi
Volume 194, Issue 1, October 2018, Pages 1-8

CRISPR‐based reagents to study the influence of the epigenome on gene expression
P. Lavender, A. Kelly, E. Hendy and P. McErlean
Volume 194, Issue 1, October 2018, Pages 9-16

Immunotherapy with oral administration of humanized anti‐CD3 monoclonal antibody: a novel gut‐immune system‐based therapy for metaflammation and NASH
Y. Ilan, K. Shailubhai and A. Sanyal
Volume 193, Issue 3, September 2018, Pages 275-283

Applications of mechanistic modelling to clinical and experimental immunology: an emerging technology to accelerate immunotherapeutic discovery and development
L.V. Brown, E.A. Gaffney, J. Wagg and M.C. Coles
Volume 193, Issue 3, September 2018, Pages 284-292

Genetics of immune‐mediated inflammatory diseases
T. David, S. F. Ling and A. Barton
Volume 193, Issue 1, July 2018, Pages 3-12

Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells
S. Alivernini, B. Tolusso, G. Ferraccioli, E. Gremese, M. Kurowska‐Stolarska and I. B. McInnes
Volume 193, Issue 1, July 2018, Pages 13-23

Stroma: the forgotten cells of innate immune memory
T. Crowley, C. D. Buckley and A. R. Clark
Volume 193, Issue 1, July 2018, Pages: 24-36

IL‐27: a double agent in the IL‐6 family
G. W. Jones, D. G. Hill, A. Cardus and S. A. Jones
Volume 193, Issue 1, July 2018, Pages 37-46

The role of the immune system in kidney disease
J. Tecklenborg D. Clayton S. Siebert S. M. Coley
Volume 192, Issue 2, May 2018, Pages 142-150

Therapeutic potential of phages in autoimmune liver diseases
A. Górski, E. Jończyk-Matysiak, M. Łusiak-Szelachowska, B. Weber-Dąbrowska, R. Międzybrodzki and J. Borysowski
Volume 192, Issue 1, April 2018, Pages 1–6

Immune checkpoint inhibitors: new strategies to checkmate cancer
R. A. M. Wilson, T. R. J. Evans, A. R. Fraser and R. J. B. Nibbs
Volume 191, Issue 2, February 2018, Pages 133–148

Self-dsDNA in the pathogenesis of systemic lupus erythematosus
Y. Bai, Y. Tong, Y. Liu and H. Hu
Volume 191, Issue 1, January 2018, Pages 1-10

Is Behçet's disease a ‘class 1-opathy’? The role of HLA-B*51 in the pathogenesis of Behçet's disease
M. Giza, D. Koftori, L. Chen and P. Bowness
Volume 191, Issue 1, January 2018, Pages 11-18

2017

The interplay between HLA-B27 and ERAP1/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis
C. Vitulano, V. Tedeschi, F. Paladini, R. Sorrentino and M. T. Fiorillo
Volume 190, Issue 3, December 2017, Pages 281-290

Current insights into the role of human β-defensins in atopic dermatitis
P. Chieosilapatham, H. Ogawa and F. Niyonsaba
Volume 190, Issue 2, November 2017, Pages 155-166

Redundant and regulatory roles for Toll-like receptors in Leishmania infection
P. Chauhan, D. Shukla, D. Chattopadhyay and B. Saha
Volume 190, Issue 2, November 2017, Pages 167-186

Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations
N. Verma, S. O. Burns, L. S. K. Walker and D. M. Sansom
Volume 190, Issue 1, October 2017, Pages 1-7

Exosomes carrying immunoinhibitory proteins and their role in cancer
T. L. Whiteside
Volume 189, Issue 3, September 2017, Pages 259–267

Reconstitution of immune cell populations in multiple sclerosis patients after autologous stem cell transplantation
F. G. Karnell, D. Lin, S. Motley, T. Duhen, N. Lim, D. J. Campbell, L. A. Turka, H. T. Maecker and K. M.
Volume 189, Issue 3, September 2017, Pages 268–278

Operational tolerance in kidney transplantation and associated biomarkers
A. Massart, L. Ghisdal, M. Abramowicz and D. Abramowicz
Volume 189, Issue 2, August 2017, Pages 138-157

Transplantation tolerance: don't forget about the B cells
A. S. Chong and S. H. Khiew
Volume 189, Issue 2, August 2017, Pages 171-180

Murine models of transplantation tolerance through mixed chimerism: advances and roadblocks
B. Mahr and T. Wekerle
Volume 189, Issue 2, August 2017, Pages 181-189

Chimerism-based tolerance in organ transplantation: preclinical and clinical studies
T. Oura, A. B. Cosimi and T. Kawai
Volume 189, Issue 2, August 2017, Pages 190-196

Regulatory T cells: tolerance induction in solid organ transplantation
T. Vaikunthanathan, N. Safinia, D. Boardman, R. I. Lechler and G. Lombardi
Volume 189, Issue 2, August 2017, Pages 197-210

The role of stromal cells in inflammatory bone loss
Corinna Wehmeyer, Thomas Pap, Christopher D Buckley and Amy J Naylor
Volume 189, Issue 1, July 2017, Pages 1-11

The role of IL-6 signaling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis
Katina Schinnerling, Juan Carlos Aguillón, Diego Catalán and Lilian Soto
Volume 189, Issue 1, July 2017, Pages 12-20

Chronic Norovirus Infection and Common Variable Immunodeficiency
Jeremy Woodward, Effrossyni Gkrania-Klotsas and Dinakantha Kumararatne
Volume 188, Issue 2, June 2017, Pages 363-370

Considerations for dosing immunoglobulin in obese patients
John P. Hodkinson
Volume 188, Issue 2, June 2017, Pages 353-362

Progressive multi-focal leucoencephalopathy – driven from rarity to clinical mainstream by iatrogenic immunodeficiency
S. A. Misbah
Volume 188, Issue 2, June 2017, Pages 342-352

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency – a practical approach
S. Jolles, H. Chapel and J. Litzman
Volume 188, Issue 2, June 2017, Pages 333-341

The Role of Genomics in Common Variable Immunodeficiency Disorders
Anne-Kathrin Kienzler, Chantal E Hargreaves and Smita Y Patel
Volume 188, Issue 2, June 2017, Pages 326-332

Production of complement components by cells of the immune system
R. Lubbers, M.F. van Essen, C. van Kooten and L.A. Trouw
Volume 188, Issue 2, May 2017, Pages 183-194

The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents?
Fiona Carty, Bernard P. Mahon and Karen English
Volume 188, Issue 1, April 2017, Pages 1-11

Homeostatic migration and distribution of innate immune cells in primary and secondary lymphoid organs with ageing
J. Nikolich-Žugich and J. S. Davies
Volume 187, Issue 3, March 2017, Pages 337-344

Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: The role of aberrant expression of non-coding RNAs in T cells
N.-S. Lai, M. Koo, C.-L. Yu and M.-C. Lu
Volume 187, Issue 3, March 2017, Pages 327-336

Circulating immune cells in multiple sclerosis
Anderson P Jones, Allan G Kermode, Robyn M Lucas, William M Carroll, David Nolan and Prue H Hart
Volume 187, Issue 2, February 2017, Pages 193-203

DNA methylation alterations in the pathogenesis of lupus
Shu-Hui Chen, Qiao-Li Lv, Lei Hu, Ming-Jing Peng, Gui-Hua Wang and Bao Sun
Volume 187, Issue 2, February 2017, Pages 185-192

Adult vaccination against tetanus and diphtheria: the European perspective
B. Weinberger
Volume 187, Issue 1, January 2017, Pages 93-99

Herpes zoster and the search for an effective vaccine
Nicole Arnold and Ilhem Messaoudi
Volume 187, Issue 1, January 2017, Pages 82-92

The life cycle of a T cell after vaccination – where does immune aging strike?
Chulwoo Kim, Fengqin Fang, Cornelia M. Weyand and Jörg J. Goronzy
Volume 187, Issue 1, January 2017, Pages 71-81

Ageing and obesity similarly impair antibody responses
Daniela Frasca, Alain Diaz, Maria Romero and Bonnie B. Blomberg
Volume 187, Issue 1, January 2017, Pages 64-70

Considerations for successful cancer immunotherapy in aged hosts
Vincent Hurez, Álvaro Padrón, Robert S. Svatek and Tyler J. Curiel
Volume 187, Issue 1, January 2017, Pages 53-63

Ageing and inflammation in patients with HIV infection
M. Nasi, S. De Biasi, L. Gibellini, E. Bianchini, S. Pecorini, V. Bacca, G. Guaraldi, C. Mussini, M. Pinti and A. Cossarizza
Volume 187, Issue 1, January 2017, Pages 44-52

Intracellular signaling pathways: Targets to reverse immunosenescence
T. Fulop, J.M. Witkowski, A. Le Page, C. Fortin, G. Pawelec and A. Larbi
Volume 187, Issue 1, January 2017, Pages 35-43

Age-related alterations in immune responses to West Nile virus infection
Ruth R. Montgomery
Volume 187, Issue 1, January 2017, Pages 26-34

Innate Immune Responses in the Aging Lung
Devin M. Boe, Lisbeth A. Boule and Elizabeth J. Kovacs
Volume 187, Issue 1, January 2017, Pages 16-25

Immune senescence: Significance of the stromal microenvironment
April R. Masters, Laura Haynes, Dong-Ming Su and Donald B. Palmer
Volume 187, Issue 1, January 2017, Pages 6-15

2016

Kawasaki disease: A matter of innate immunity
Toshiro Hara, Yasutaka Nakashima, Yasunari Sakai, Hisanori Nishio, Yoshitomo Motomura and Sho Yamasaki
Volume 186, Issue 2, November 2016, Pages 134-143

Why, When and How should Immunosuppressive Therapy considered in Patients with IgA Nephropathy
Franz Maximilian Rasche, Frieder Keller, Wilma Gertrud Rasche, Stephan Schiekofer, Andreas Boldt, Ulrich Sack and Jeanette Fahnert
Volume 186, Issue 2, November 2016, Pages 115-133

The Immunology of the Vermiform Appendix: a review of the literature
Isabelle A. Kooij, Saloomeh Sahami, Sybren L. Meijer, Christianne J. Buskens and Anje A. te Velde
Volume 186, Issue 1, October 2016, Pages 1-9

Phenotypic characterization of regulatory T cells in humans and rodents
Ana Lucía Rodríguez-Perea, Eliuth David Arcia, Cesar M. Rueda and Paula A. Velilla
Volume 185, Issue 3, September 2016, Pages 281-291

Of the Multiple Mechanisms Leading to Type 1 Diabetes, TCR Revision May Play a Prominent Role (Is Type 1 Diabetes More Than A Single Disease?)
David H. Wagner
Volume 185, Issue 3, September 2016, Pages 271-280

Interleukin-9 and T helper type 9 cells in rheumatic diseases
F. Ciccia, G. Guggino, A. Ferrante, P. Cipriani, R. Giacomelli and G. Triolo
Volume 185, Issue 2, August 2016, Pages 125-132

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Christian Klemann, Leona Wagner, Michael Stephan and Stephan von Hörsten
Volume 185, Issue 1, July 2016, Pages 1-21

Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins
L. Wagner, C. Klemann, M. Stephan and S. von Hörsten
Volume 184, Issue 3, June 2016, Pages 265-283

Regulatory T cells and minimal change nephropathy: in the midst of a complex network
R. Bertelli, A. Bonanni, A. Di Donato, M. Cioni, P. Ravani and G. M. Ghiggeri
Volume 183, Issue 2, February, Pages 166-174

Immunology of membranous nephropathy: from animal models to humans
R. A. Sinico, N. Mezzina, B. Trezzi, GM. Ghiggeri and A. Radice
Volume 183, Issue 2, February 2016, Pages 157-165

From the bench to clinical practice: understanding the challenges and uncertainties in immunogenicity testing for biopharmaceuticals
G. R. Gunn III, D. C. F. Sealey, F. Jamali, B. Meibohm, S. Ghosh and G. Shankar
Volume 184, Issue 2, May 2016, Pages 137-146

Transcription factors regulating B cell fate in the germinal centre
T. Recaldin and D. J. Fear
Volume 183, Issue 1, January 2016, Pages 65-75

Eosinophils: important players in humoral immunity
C. Berek
Volume 183, Issue 1, January 2016, Pages 57-64

The ageing human B cell repertoire: a failure of selection?
D. K. Dunn-Walters
Volume 183, Issue 1, January 2016, Pages 50-56

RNA binding proteins as regulators of immune cell biology
R. Newman, J. McHugh and M. Turner
Volume 183, Issue 1, January 2016, Pages 37-49

CD4 T cell differentiation in type 1 diabetes
L. S. K. Walker and M. von Herrath
Volume 183, Issue 1, January 2016, Pages 16-29

2015

Permissive and protective roles for neutrophils in leishmaniasis
E. D. Carlsen, Y. Liang, T. R. Shelite, D. H. Walker, P. C. Melby and L. Soong
Volume 182, Issue 2, November 2015, Pages 109-240

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium
B. Rup, M. Pallardy, D. Sikkema, T. Albert, M. Allez, P. Broet, C. Carini, P. Creeke, J. Davidson, N. De Vries, D. Finco, A. Fogdell-Hahn, E. Havrdova, A. Hincelin-Mery, M. C. Holland, P. E. H. Jensen, E. C. Jury, H. Kirby, D. Kramer, S. Lacroix-Desmazes, J. Legrand, E. Maggi, B. Maillère, X. Mariette, C. Mauri, V. Mikol, D. Mulleman, J. Oldenburg, G. Paintaud, C. R. Pedersen, N. Ruperto, R. Seitz, S. Spindeldreher, F. Deisenhammer and on behalf of the ABIRISK Consortium
Volume 181, Issue 3, September 2015, Pages 385-400

Immunology of IgG4-related disease
E. Della-Torre, M. Lanzillotta and C. Doglioni
Volume 181, Issue 2, August 2015, Pages 191-206

The T cell antigen receptor: the Swiss army knife of the immune system
M. Attaf, M. Legut, D. K. Cole and A. K. Sewell
Volume 181, Issue 1, July 2015, Pages 1-18

The complex pathophysiology of acquired aplastic anaemia
Y. Zeng and E. Katsanis
Volume 180, Issue 3, June 2015, Pages 361-370

Novel therapies for memory cells in autoimmune diseases
P. Bhargava and P. A. Calabresi
Volume 180, Issue 3, June 2015, Pages 353-360

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious diseases
C. Skevaki, M. Pararas, K. Kostelidou, A. Tsakris and J. G. Routsias
Volume 180, Issue 2, Mayl 2015, Pages 165-177

Harnessing the power of Vδ2 cells in cancer immunotherapy
D. W. Fowler and M. D. Bodman-Smith
Volume 180, Issue 1, April 2015, Pages 1-10

Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota
C. T. Peterson, V. Sharma, L. Elmén and S. N. Peterson
Volume 179, Issue 3, March 2015, Pages 363-377

The role of T and B cells in human atherosclerosis and atherothrombosis
E. Ammirati, F. Moroni, M. Magnoni and P. G. Camici
Volume 179, Issue 2, February 2015, Pages 173-187

Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats
O. Guttman, B. M. Baranovski, R. Schuster, Z. Kaner, G. S. Freixo-Lima, N. Bahar, N. Kalay, M. I. Mizrahi, I. Brami, D. E. Ochayon and E. C. Lewis
Volume 179, Issue 2, February 2015, Pages 161-172

Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease
S. Jolles, J. S. Orange, A. Gardulf, M. R. Stein, R. Shapiro, M. Borte and M. Berger
Volume 179, Issue 2, February 2015, Pages 146-160

Angiotensin II in inflammation, immunity and rheumatoid arthritis
Y. Chang and W. Wei
Volume 179, Issue 2, February 2015, Pages 137-145

The effects of diet-induced obesity on B cell function
S. R. Shaikh, K. M. Haas, M. A. Beck and H. Teague
Volume 179, Issue 1, January 2015, Pages 90-99

CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis – from bench to bedside?
L. Schiffer, K. Worthmann, H. Haller and M. Schiffer
Volume 179, Issue 1, January 2015, Pages 85-89

The effect of cell death in the initiation of lupus nephritis
K. Fenton
Volume 179, Issue 1, January 2015, Pages 11-16

Anti-dsDNA antibodies as a classification criterion and a diagnostic marker for systemic lupus erythematosus: critical remarks
O. P. Rekvig
Volume 179, Issue 1, January 2015, Pages 5-10

2014

Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications
E. M. Moran and F. L. Mastaglia
Volume 178, Issue 3, December 2014, Pages 405-415

The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells
K. Jovanovic, M. Siebeck and R. Gropp
Volume 178, Issue 2, November 2014, Pages 201-211

Enhancement of T cell recruitment and infiltration into tumours
C. Oelkrug and J. M. Ramage
Volume 178, Issue 1, October 2014, Pages 1-8

Emerging role of leptin in rheumatoid arthritis
G. Tian, J.-N. Liang, Z.-Y. Wang and D. Zhou
Volume 177, Issue 3, September 2014, Pages 557-570

Helminths in the hygiene hypothesis: sooner or later?
R. M. Maizels, H. J. McSorley and D. J. Smyth
Volume 177, Issue 1, July 2014, Pages 38-46

The intestinal microbiome in type 1 diabetes
J. L. Dunne, E. W. Triplett, D. Gevers, R. Xavier, R. Insel, J. Danska and M. A. Atkinson
Volume 177, Issue 1, July 2014, Pages 30-37

Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus
S. D. Udayappan, A. V. Hartstra, G. M. Dallinga-Thie and M. Nieuwdorp
Volume 177, Issue 1, July 2014, Pages 24-29

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis
M. A. Pineda, L. Al-Riyami, W. Harnett and M. M. Harnett
Volume 177, Issue 1, July 2014, Pages 13-23

Microbial ‘old friends’, immunoregulation and socioeconomic status
G. A. W. Rook, C. L. Raison and C. A. Lowry
Volume 177, Issue 1, July 2014, Pages 1-12

Interleukin-6 blockade in ocular inflammatory diseases
M. Mesquida, A. Leszczynska, V. Llorenç and A. Adán
Volume 176, Issue 3, June 2014, Pages 301-309

If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it?
D. P. Eisen and M. Osthoff
Volume 176, Issue 2, May 2014, Pages 165-171

Neuromyelitis optica: clinical features, immunopathogenesis and treatment
S. Jarius, B. Wildemann and F. Paul
Volume 176, Issue 2, May 2014, Pages 149-164

Management of disease-modifying treatments in neurological autoimmune diseases of the central nervous system
A. Salmen, R. Gold and A. Chan
Volume 176, Issue 2, May 2014, Pages 135-148

HIV-exposed uninfected children: a growing population with a vulnerable immune system?
L. Afran, M. Garcia Knight, E. Nduati, B. C. Urban, R. S. Heyderman and S. L. Rowland-Jones
Volume 176, Issue 1, April 2014, Pages 11-22

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases
H. Patterson, R. Nibbs, I. McInnes and S. Siebert
Volume 176, Issue 1, April 2014, Pages 1-10

Multiple sclerosis treatment and infectious issues: update 2013
A. Winkelmann, M. Loebermann, E. C. Reisinger and U. K. Zettl
Volume 175, Issue 3, March 2014, Pages 425-438

Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls
P. Berlit and M. Kraemer
Volume 175, Issue 3, March 2014, Pages 419-424

Myasthenia gravis: an update for the clinician
J. P. Sieb
Volume 175, Issue 3, March 2014, Pages 408-418

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview
P. S. Rommer, U. K. Zettl, B. Kieseier, H.-P. Hartung, T. Menge, E. Frohman, B. M. Greenberg, B. Hemmer and O. Stüve
Volume 175, Issue 3, March 2014, Pages 397-407

CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disorders
A. Dudesek, F. Rimmele, S. Tesar, S. Kolbaske, P. S. Rommer, R. Benecke and U. K. Zettl
Volume 175, Issue 3, March 2014, Pages 385-396

Monoclonal antibodies in treatment of multiple sclerosis
P. S. Rommer, A. Dudesek, O. Stüve and U.K. Zettl
Volume 175, Issue 3, March 2014, Pages 373-384

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies
N. Melzer and S. G. Meuth
Volume 175, Issue 3, March 2014, Pages 359-372

Diagnosis, pathogenesis and treatment of myositis: recent advances
P. -O. Carstens and J. Schmidt
Volume 175, Issue 3, March 2014, Pages 349-358

Paraneoplastic neurological syndromes
F. Leypoldt and K.-P. Wandinger
Volume 175, Issue 3, March 2014, Pages 336-348

Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum
G. A. Ramirez, N. Maugeri, M. G. Sabbadini, P. Rovere-Querini and A. A. Manfredi
Volume 175, Issue 2, February 2014, Pages 150-166

Molecular diagnosis of chronic granulomatous disease
D. Roos and M. de Boer
Volume 175, Issue 2, February 2014, Pages 139-149

Aicardi–Goutières syndrome: a model disease for systemic autoimmunity
M. A. Lee-Kirsch, C. Wolf and C. Günther
Volume 175, Issue 1, January 2014, Pages 17-24

Mouse models for Aicardi–Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity
R. Behrendt and A. Roers
Volume 175, Issue 1, January 2014, Pages 9-16

Therapies in Aicardi–Goutières syndrome
Y. J. Crow, A. Vanderver, S. Orcesi, T. W. Kuijpers and G. I. Rice
Volume 175, Issue 1, January 2014, Pages 1-8

2013

New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin
R. Ameratunga, S.-T. Woon, D. Gillis, W. Koopmans and R. Steele
Volume 174, Issue 2, November 2013, Pages 203-211

Alveolar macrophages in pulmonary host defence – the unrecognized role of apoptosis as a mechanism of intracellular bacterial killing
J. D. Aberdein, J. Cole, M. A. Bewley, H. M. Marriott and D. H. Dockrell
Volume 174, Issue 2, November 2013, Pages 193-202

Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism
S. Yamazaki, A. Kanamoto and T. Takayama
Volume 173, Issue 2, August 2013, Pages 173-178

The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses
S. Modi, M. Soejima and M. C. Levesque
Volume 173, Issue 1, July 2013, Pages 8-17

Progress in immune-based therapies for type 1 diabetes
M. von Herrath, M. Peakman and B. Roep
Volume 172, Issue 2, May 2013, Pages 186-202

Immunological biomarkers: Catalysts for translational advances in autoimmune diabetes
S. T. Ahmed, E. Akirav, E. Bradshaw, J. Buckner, E. McKinney, F. J. Quintana, F. Waldron-Lynch and J. Nepom
Volume 172, Issue 2, May 2013, Pages 178-185

Whole-body imaging of adoptively transferred T cells using magnetic resonance imaging, single photon emission computed tomography and positron emission tomography techniques, with a focus on regulatory T cells
J. M. Leech, E. Sharif-Paghaleh, J. Maher, L. Livieratos, R. I. Lechler, G. E. Mullen, G. Lombardi and L. A. Smyth
Volume 172, Issue 2, May 2013, Pages 169-177

Promoting transplantation tolerance; adoptive regulatory T cell therapy
N. Safinia, J. Leech, M. Hernandez-Fuentes, R. Lechler and G. Lombardi
Volume 172, Issue 2, May 2013, Pages 158-168

Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
C. M. U. Hilkens and J. D. Isaacs
Volume 172, Issue 2, May 2013, Pages 148-157

T cell depletion in paediatric stem cell transplantation
C. Booth and P. Veys
Volume 172, Issue 2, May 2013, Pages 139-147

Protecting against plague: towards a next-generation vaccine
E. D. Williamson and P. C. F. Oyston
Volume 172, Issue 1, April 2013, Pages 1-8

Experimental models to investigate the function of dendritic cell subsets: challenges and implications
D. G. Hancock, T. V. Guy, E. Shklovskaya and B. Fazekas de St Groth
Volume 171, Issue 2, February 2013, Pages 147-154

Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus
A. E. Barcala Tabarrozzi, C. N. Castro, R. A. Dewey, M. C. Sogayar, L. Labriola and M. J. Perone
Volume 171, Issue 2, February 2013, Pages 135-146

To B or not to B cells-mediate a healthy start to life
T. G. Nguyen, C. M. Ward and J. M. Morris
Volume 171, Issue 2, February 2013, Pages 124-134

Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis
R. J. Boyton, C. J. Reynolds, K. J. Quigley and D. M. Altmann
Volume 171, Issue 2, February 2013, Pages 117-123

Suppression, subversion and escape: the role of regulatory T cells in cancer progression
K. Oleinika, R. J. Nibbs, G. J. Graham and A. R. Fraser
Volume 171, Issue 1, January 2013, Pages 36-45

The role of stromal cells in the persistence of chronic inflammation
A. J. Naylor, A. Filer and C. D. Buckley
Volume 171, Issue 1, January 2013, Pages 30-35

Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease
E. Zonneveld-Huijssoon, S. Albani, B. J. Prakken and F. van Wijk
Volume 171, Issue 1, January 2013, Pages 20-29

Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
Y. Simoni, J. Diana, L. Ghazarian, L. Beaudoin and A. Lehuen
Volume 171, Issue 1, January 2013, Pages 8-19

CD73 and adenosine generation in the creation of regulatory microenvironments
F. S. Regateiro, S. P. Cobbold and H. Waldmann
Volume 171, Issue 1, January 2013, Pages 1-7